Dry Eye Disease and Dehydration Overview Can greater habitual water intake lower the risk of dry eye disease (DED)? Dry eye disease is a complex disease of the tear film and ocular surface. It causes discomfort, visual disturbance, and the risk of damage to the ocular surface. DED is a condition when a
Tag: ophthalmology
macular edema therapy using dexamethasone nanoparticle suspension
macular edema therapy using dexamethasone nanoparticle suspension PURPOSE To determine the effectiveness and safety of a new topical nanoparticle dexamethasone ophthalmic suspension OCS-01 (Oculis SA, Lausanne, Switzerland) in the treatment of diabetic macular edema (DME). STUDY BACKGROUND Diabetic macular edema (DME) is the main cause of visual impairment in patients with diabetic retinopathy (DR).
Cholesterol Screening To Aid In Glaucoma Detection
Cholesterol Screening To Aid In Glaucoma Detection Overview Although intraocular pressure is the primary risk factor for glaucoma, additional risk factors should also be considered. This systematic review and meta-analysis summarize the evidence of the association between cholesterol parameters (total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels) and glaucoma and
Why Vision Screening is Important
Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. Why Vision Screening is Important At least 2.2 billion people across the world have visual impairment Are you wondering how you can ease your eye strain? Or are you someone who
How to Control Eye Pressure in Glaucoma
Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. How to Control Eye Pressure in Glaucoma The irreversible damage of glaucoma is one of the leading causes of blindness among people ages 60 years and above(1). This condition is
Optic 3D Modeling in Ophthalmic Treatment
Optic 3D Modeling in Ophthalmic Treatment Visual impairment is a global health concern. Visually impaired patients are at high risk for accidents, depression, and social withdrawal. Eye disorders like age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP) cause irreparable vision loss and affect the quality of life of
iStent Combination Therapy for Glaucoma and Cataracts
iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value.
Second Primary Malignancies of Eye and Ocular Adnexa
Thermography in clinical ophthalmic oncology
THERMOGRAPHY AS A SCREENING TOOL IN CLINICAL OPHTHALMIC ONCOLOGY STUDY BACKGROUND Although intraocular tumors are rare, with an incidence of 5 per million adults, the diagnosis has been biased towards the physical examination, Color Doppler Imaging (CDI), Optical Coherence Tomography (OCT), Indocyanine Green Angiography (ICGA), or Fluorescein Angiography (FA). Literature reviews suggest
Combination IOP Reduction Therapy in Open-Angle Glaucoma
Combination IOP Reduction Therapy in Open-Angle Glaucoma GLAUCOMA BACKGROUND Globally, glaucoma is a leading cause of permanent blindness. As of 2020, about 80 million people worldwide, and 3 million Americans, are affected by glaucoma. The most common form of glaucoma is open-angle glaucoma. Unfortunately, the primary risk factor for open-angle glaucoma is
